{"nct_id":"NCT06093503","title":"Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein","status":"WITHDRAWN","status_verified_date":"2024-06","start_date":"2024-05-31","start_date_type":"ESTIMATED","primary_completion_date":"2028-04-11","primary_completion_date_type":"ESTIMATED","completion_date":"2028-04-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}